IBA Particle Therapy India Emerges L1 with ₹456 Cr Bid for Guwahati Proton Beam Therapy Unit
Financial Evaluation Key Takeaways
- ✓ IBA Particle Therapy India Private Limited is the sole L1 bidder.
- ✓ L1 bid quoted at ₹456.0 crore for the project.
- ✓ Project involves procurement and commissioning of a Proton Beam Therapy Unit in Guwahati.
- ✓ Tender floated by Medical Education and Research Department- Externally Aided Project, Assam.
- ✓ Only one bidder participated and qualified technically.
- ✓ Contract not yet awarded; L1 status is provisional.
IBA Particle Therapy India Private Limited has emerged as the L1 (lowest) bidder with a ₹456 crore offer for the procurement of a Proton Beam Therapy Unit in Guwahati, Assam, as per the financial bid results opened by the Medical Education and Research Department.
In a significant development for Assam's healthcare infrastructure, IBA Particle Therapy India Private Limited has emerged as the L1 (lowest) bidder for the procurement of a Proton Beam Therapy Unit at Guwahati. The financial bids, opened on 6 February 2026, revealed IBA's offer of ₹456.0 crore for the project.
The tender, floated by the Medical Education and Research Department- Externally Aided Project, aims to bring advanced cancer treatment technology to Kamrup Metro, Assam. The result, declared on 22 July 2026, marks a major step towards enhancing medical equipment capabilities in the region.
The Award
IBA Particle Therapy India Private Limited has emerged as the L1 (lowest) bidder with a quoted price of ₹456.0 crore for the procurement, installation, testing, and commissioning of a Proton Beam Therapy Unit at Guwahati. The contract is yet to be formally awarded.
Bidders (1)
About the Project
- Procurement of a Proton Beam Therapy Unit for Guwahati, Assam.
- Scope includes installation, testing, and commissioning of the medical equipment.
- Project is under the Medical Education and Research Department- Externally Aided Project.
- Located in Kamrup Metro, Assam.
Why It Matters
This project is set to introduce cutting-edge proton beam therapy technology to Assam, potentially improving cancer treatment outcomes and expanding advanced healthcare services in the region.
With IBA Particle Therapy India Private Limited emerging as the L1 bidder, the project now awaits formal contract award. The move signals Assam's commitment to upgrading its medical infrastructure with state-of-the-art equipment.
